<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00138684</url>
  </required_header>
  <id_info>
    <org_study_id>DGS 2003/0052</org_study_id>
    <secondary_id>PHRC/02-09</secondary_id>
    <secondary_id>CIC0203/015</secondary_id>
    <nct_id>NCT00138684</nct_id>
  </id_info>
  <brief_title>Cytochrome P450 2E1 and Iron Overload</brief_title>
  <official_title>Cytochrome P450 2E1 and Iron Overload</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine, in patients presenting hepatic iron overload (genetic
      haemochtomatisis or dysmetabolic iron overload syndrome), the effects of venesection therapy
      on cytochrome P450 2E1 activity by comparing the rates of metabolization of chlorzoxazone
      before and after venesection.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">February 2006</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>variation of chlorzoxazone metabolization rate measured before and after venesection</measure>
    <time_frame>Baseline and after iron desaturation completion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>variation of blood Malonedialdehyde rate</measure>
    <time_frame>Baseline and after iron desaturation completion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>variation of blood 4-hydroxynonenal rate</measure>
    <time_frame>Baseline and after iron desaturation completion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>variation of blood Glutathion rate</measure>
    <time_frame>Baseline and after iron desaturation completion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>variation of serum Vitamin E rate</measure>
    <time_frame>Baseline and after iron desaturation completion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of serum Vitamin C rate</measure>
    <time_frame>Baseline and after iron desaturation completion</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Insulin Resistance</condition>
  <condition>Iron Overload</condition>
  <arm_group>
    <arm_group_label>Venesection therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>no venesection therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>venesection</intervention_name>
    <description>Venesection therapy is realised every 7 - 14 days until iron desaturation completion.</description>
    <arm_group_label>Venesection therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male patients aged from 18 to 70 years

          -  Hepatic iron overload measured by magnetic resonance imaging [MRI] (&gt; 36 µmol/g and &lt;
             200 µmol/L)

          -  Homozygosity for the C282Y mutation of the HFE or dysmetabolic iron overload syndrome
             (DIOS) based on the presence of at least one of these following metabolic
             abnormalities:

          -  Overweight: BMI &gt; 25 kg/m2

          -  Waist/hip circumference (cm) &gt; 0.90

          -  Diabetes mellitus (fasting blood glucose level &gt;1.25g/L or blood glucose level after 2
             hours &gt; 2g/L) or glucose intolerance (fasting blood glucose level between 1.10 and
             1.25g/L)

          -  Total cholesterolemia &gt; 6.2 mmol/L or HDL-Cholesterol &lt; 0.9 mmol/L

          -  TG&gt;= 1.7 mmol

          -  Written informed consent

        Non-Inclusion Criteria:

          -  Consumption of alcohol &gt; 50 g/day and of any CYP2E1 inhibitor substances

          -  Smoker &gt; 5 cigarets/day

          -  History of blood donation or venesection

          -  Other causes of iron overload: aceruloplasminaemia, haematological disorder (abnormal
             blood counting), late cutaneous porphyria (cutaneous bullous disorders and
             photosensibilisation) , martial treatment, repeated transfusions.

          -  Inflammatory syndrome (CRP &gt; 3ng/ml)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel Reymann, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Rennes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabrice Lainé, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Rennes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unité d'Investigation Clinique - Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2005</study_first_submitted>
  <study_first_submitted_qc>August 29, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2005</study_first_posted>
  <last_update_submitted>May 18, 2012</last_update_submitted>
  <last_update_submitted_qc>May 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2012</last_update_posted>
  <keyword>insulin resistance</keyword>
  <keyword>iron overload</keyword>
  <keyword>phlebotomy</keyword>
  <keyword>hepatic iron overload</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Iron Overload</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

